177 filings
Page 9 of 9
6-K
MDNAF
Medicenna Therapeutics Corp.
1 Oct 20
Dr. Jack Geltosky Elected to Medicenna Board of Directors
12:00am
6-K
MDNAF
Medicenna Therapeutics Corp.
11 Sep 20
Current report (foreign)
11:06am
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Sep 20
Medicenna to Present at Upcoming Investor Conferences in September
8:29am
6-K
MDNAF
Medicenna Therapeutics Corp.
4 Sep 20
Current report (foreign)
2:50pm
6-K
MDNAF
Medicenna Therapeutics Corp.
27 Aug 20
Form 51-102F3 Material Change Report
3:09pm
6-K
MDNAF
Medicenna Therapeutics Corp.
24 Aug 20
Notice of Change of Auditor
4:54pm
6-K
MDNAF
Medicenna Therapeutics Corp.
21 Aug 20
Current report (foreign)
10:30am
CERT
MDNAF
Medicenna Therapeutics Corp.
21 Aug 20
Certification of approval for exchange listing
10:20am
8-A12B
MDNAF
Medicenna Therapeutics Corp.
18 Aug 20
Registration of securities on exchange
11:24am
6-K
MDNAF
Medicenna Therapeutics Corp.
5 Aug 20
Condensed Consolidated Interim Statements of Financial Position
12:29pm
S-8
MDNAF
Medicenna Therapeutics Corp.
31 Jul 20
Registration of securities for employees
8:43am
EFFECT
MDNAF
Medicenna Therapeutics Corp.
31 Jul 20
Notice of effectiveness
7:40am
F-10/A
MDNAF
Medicenna Therapeutics Corp.
28 Jul 20
Registration of securities (Canada) (amended)
5:17pm
F-X
MDNAF
Medicenna Therapeutics Corp.
3 Jun 20
Appointment of agent for service of process by issuers registering securities
4:12pm
F-10
MDNAF
Medicenna Therapeutics Corp.
3 Jun 20
Registration of securities (Canada)
3:54pm
D/A
MDNAF
Medicenna Therapeutics Corp.
20 Apr 20
$9.22M in equity, sold $9.22M, 6 investors
2:25pm
D
MDNAF
Medicenna Therapeutics Corp.
30 Mar 20
$6.72M in equity, sold $6.72M, 4 investors
12:38pm